Healthicare Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: moving between compounded and brand without changing seller
Healthicare's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
No insurance needed · Vetted by our editors
Two names Healthicare puts in public that most of this segment keeps quiet: Beluga Health, its clinical partner, and Jungle Jim's Pharmacy of Fairfield, OH, which dispenses. Coverage on this GLP-1 telehealth platform reaches 44 states. Compounded semaglutide opens at $147.90/mo, compounded tirzepatide at $224.40/mo. One account also reaches the full brand menu, Zepbound, Mounjaro, Wegovy, and Ozempic.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Healthicare
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Healthicare at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro
- Starting price
- $150/mo ($149.99 first month ($100 off), $249.99/mo after)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Coaching
- FDA status
- No FDA warning letter on record
How Healthicare scores
Six columns, each one computed from something Healthicare has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
5.6/10$174/month is 8% below the register median of $189 for compounded semaglutide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
6.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
8.5/10The price covers medication, consult, shipping, coaching.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Healthicare
Last checked August 2026- Re-read the price on file across 4 dose or plan tiers
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with Healthicare involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Healthicare publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3Healthicare does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- 4The monthly price is recorded as covering medication, consult, shipping, coaching.
- Cheapest standing monthly prices on record: semaglutide $174, tirzepatide $264. Membership fees, first-month rates and insured copays are excluded from those figures.
- No state list is published, so whether Healthicare serves your state cannot be confirmed from its site.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Healthicare support, as documented
- Phone
- 618-740-4204
GLP-1 medications Healthicare offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
$174/mo billed monthly; $147.90/mo on the 3-month plan ($443.70 billed every 3 months)
$264/mo billed monthly; $224.40/mo on the 3-month plan ($673.20 billed every 3 months)
$149.99 first month ($100 off), $249.99/mo after
From $1,299.99/mo; first month From $1,199.99 ($100 off)
Check the price yourself before you pay
Every figure here was read off Healthicare's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide at $174 a month, within the normal band around this register's $189 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping, coaching
- No FDA warning letter matched this operator when we searched our enforcement register
- Both oral and injectable options are on record, so the format is a choice rather than a condition
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Healthicare charges
The figure Healthicare leads with is $150, and it is a first-month rate. From month two the price is $174/month, which is the number to plan around. Nothing improper about an introductory offer — it just is not the price of staying on the medication.
- Compounded semaglutide — $174/month
- Compounded tirzepatide — $264/month
- semaglutide — $150 first month, then $250/month
- Brand-name semaglutide — $1200 first month, then $1300/month
The median across the GLP-1 providers we track is about $169/month, so this lands mid-market — close enough that the deciding factor is unlikely to be price.
Found dispenses semaglutide and tirzepatide from $149/month, which makes it the honest comparison to run before committing here.
What Healthicare dispenses
Healthicare prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference.
What we could verify
On the record: coaching is included rather than sold on top. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will be paying in month three.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- you want the price to stop moving as your dose climbs
- you want a cheap way to find out whether the medication suits you before committing
- you want coaching bundled rather than metered
Our read
Healthicare is a cheap way to start and an ordinary way to continue. Use the $150 month for what it is good for — establishing whether the medication works for you — and re-run the numbers against $174/month before you let it renew twice. Breeze Meds is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
Healthicare's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Before you pay Healthicare
Starting at $174/month. Check today's price, then book the free consultation.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Healthicare review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Healthicare's current pricing
Plans start at $174/month. The free consultation is where you learn whether you qualify, and what it costs today.